Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDIV × Bimatoprost × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Hypotrichosis 1

Interventions

Proflavine 3 Microbial Collagenase 2 sargramostim 1 pembrolizumab 1 pegfilgrastim 1 macimorelin 1 keyhole-limpet hemocyanin 1 Sodium Chloride 1 Sirolimus 1 Peptides 1 Monatide (IMS 3015) 1 Ipilimumab 1 Gemcitabine 1 Everolimus 1 Bimatoprost 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01387906 2012-06-15

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Beer, Kenneth R., M.D., PA

Phase 4 Completed

Hypotrichosis, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡